Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 7, Pages 1916
Publisher
MDPI AG
Online
2018-06-29
DOI
10.3390/ijms19071916
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Emerging Pathway of Doxorubicin Cardiotoxicity Mediated through CYP2J2
- (2018) William R. Arnold et al. BIOCHEMISTRY
- CYP2J2 Expression in Adult Ventricular Myocytes Protects Against Reactive Oxygen Species Toxicity
- (2018) Eric A. Evangelista et al. DRUG METABOLISM AND DISPOSITION
- GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells
- (2018) Sang-Kyu Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enzymatic and free radical formation of cis - and trans - epoxyeicosatrienoic acids in vitro and in vivo
- (2017) Theresa Aliwarga et al. FREE RADICAL BIOLOGY AND MEDICINE
- Association of CYP2J2 gene polymorphisms with ischemic stroke and stroke subtypes in Chinese population
- (2017) Si-Yang Wang et al. MEDICINE
- Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy
- (2017) Jiong Hu et al. NATURE
- Influence of ABCC2, CYP2C8 , and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients
- (2017) Fabiana D. V. Genvigir et al. PHARMACOTHERAPY
- Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
- (2017) Melissa Skibba et al. Frontiers in Pharmacology
- CYP2J2 and Its Metabolites EETs Attenuate Insulin Resistance via Regulating Macrophage Polarization in Adipose Tissue
- (2017) Meiyan Dai et al. Scientific Reports
- CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1
- (2016) Bei Wang et al. AGING CELL
- CYP2J2-Derived EETs Attenuated Angiotensin II-Induced Adventitial Remodeling via Reduced Inflammatory Response
- (2016) Chi Zhou et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- CYP2J2 Overexpression Increases EETs and Protects Against HFD-Induced Atherosclerosis in ApoE−/− Mice
- (2016) Wanjun Liu et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ
- (2015) Rui Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The role of epoxyeicosatrienoic acids in the cardiovascular system
- (2015) L. Yang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II
- (2015) Zuowen He et al. CARDIOVASCULAR RESEARCH
- Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study
- (2015) Akinyemi Oni-Orisan et al. JOURNAL OF LIPID RESEARCH
- Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population
- (2015) Annan Sudarsan Arun Kumar et al. Pharmacological Reports
- An Optimized High Throughput Clean-Up Method Using Mixed-Mode SPE Plate for the Analysis of Free Arachidonic Acid in Plasma by LC-MS/MS
- (2015) Wan Wang et al. International Journal of Analytical Chemistry
- Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo
- (2014) Rüdiger Kaspera et al. BIOCHEMICAL PHARMACOLOGY
- CYP2J2 Targeting to Endothelial Cells Attenuates Adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet by Reprogramming Adipocyte Phenotype
- (2014) Nader G. Abraham et al. HYPERTENSION
- Determination of Free Fatty Acids in Human Serum by HPLC with Fluorescence Detection
- (2014) Minami Nishikiori et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- Arachidonic Acid-enriched Triacylglycerol Improves Cognitive Function in Elderly with Low Serum Levels of Arachidonic Acid
- (2014) Hisanori Tokuda et al. Journal of Oleo Science
- Important Role of CYP2J2 in Protein Kinase Inhibitor Degradation: A Possible Role in Intratumor Drug Disposition and Resistance
- (2014) Céline Narjoz et al. PLoS One
- Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients
- (2013) Robert N. Schuck et al. ATHEROSCLEROSIS
- A Common Polymorphism G-50T in Cytochrome P450 2J2 Gene Is Associated with Increased Risk of Essential Hypertension in a Russian Population
- (2013) Alexey V. Polonikov et al. DISEASE MARKERS
- Cardiac-Specific Overexpression of CYP2J2 Attenuates Diabetic Cardiomyopathy in Male Streptozotocin-Induced Diabetic Mice
- (2013) Ben Ma et al. ENDOCRINOLOGY
- Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity
- (2013) Md. Abdul Hye Khan et al. FASEB JOURNAL
- CYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice
- (2013) Zhejun Cai et al. JOURNAL OF LIPID RESEARCH
- 5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone
- (2013) Magali Cazade et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Inducible CYP2J2 and Its Product 11,12-EET Promotes Bacterial Phagocytosis: A Role for CYP2J2 Deficiency in the Pathogenesis of Crohn’s Disease?
- (2013) Jonas Bystrom et al. PLoS One
- CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy
- (2013) Christina Westphal et al. PLoS One
- Roles of the epoxygenase CYP2J2 in the endothelium
- (2013) Ara Askari et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?
- (2013) Arturo D. Mancini et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease
- (2012) Katherine N. Theken et al. ATHEROSCLEROSIS
- Cytochrome P450 Subfamily 2J Polypeptide 2 Expression and Circulating Epoxyeicosatrienoic Metabolites in Preeclampsia
- (2012) Florian Herse et al. CIRCULATION
- CYP2J2 −50 G/T and ADRB2 G46A Gene Polymorphisms in Saudi Subjects with Hypertension
- (2012) Abdullah Alghasham et al. Genetic Testing and Molecular Biomarkers
- Delivery of AAV2-CYP2J2 Protects Remnant Kidney in the 5/6-Nephrectomized Rat via Inhibition of Apoptosis and Fibrosis
- (2012) Gang Zhao et al. HUMAN GENE THERAPY
- Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells
- (2012) Jun Ma et al. JOURNAL OF LIPID RESEARCH
- Role of PI3Kα and sarcolemmal ATP-sensitive potassium channels in epoxyeicosatrienoic acid mediated cardioprotection
- (2012) Sri N. Batchu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice
- (2012) Ketul R. Chaudhary et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart
- (2011) Matthew L. Edin et al. FASEB JOURNAL
- Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice
- (2011) Guangzhi Chen et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Eicosanoids, β-cell function, and diabetes
- (2011) Pengcheng Luo et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Gene Delivery of Cytochrome P450 Epoxygenase Ameliorates Monocrotaline-Induced Pulmonary Artery Hypertension in Rats
- (2010) Changlong Zheng et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The common functional polymorphism -50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes
- (2010) Cristiano Fava et al. JOURNAL OF HYPERTENSION
- Electrophysiological remodeling in heart failure
- (2010) Yanggan Wang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis
- (2010) P. Luo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Overexpression of Cytochrome P450 Epoxygenases Prevents Development of Hypertension in Spontaneously Hypertensive Rats by Enhancing Atrial Natriuretic Peptide
- (2010) B. Xiao et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Up-Regulation of Human CYP2J2 in HepG2 Cells by Butylated Hydroxyanisole Is Mediated by c-Jun and Nrf2
- (2010) A. C. Lee et al. MOLECULAR PHARMACOLOGY
- Epoxyeicosatrienoic acids and endothelium-dependent responses
- (2010) William B. Campbell et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease
- (2010) Oliver Jung et al. PLoS One
- Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism
- (2010) Veronique Michaud et al. PLoS One
- Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity
- (2009) Yunfang Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function
- (2009) F. Dutheil et al. DRUG METABOLISM AND DISPOSITION
- Identification of Novel Substrates for Human Cytochrome P450 2J2
- (2009) C. A. Lee et al. DRUG METABOLISM AND DISPOSITION
- Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology
- (2009) Rüdiger Kaspera et al. Expert Opinion on Drug Metabolism & Toxicology
- Protective actions of epoxyeicosatrienoic acid: Dual targeting of cardiovascular PI3K and KATP channels
- (2009) Sreedhar Bodiga et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The Epoxygenases CYP2J2 Activates the Nuclear Receptor PPARα In Vitro and In Vivo
- (2009) Jessica A. Wray et al. PLoS One
- The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile
- (2008) Jan Börgel et al. BMC Cardiovascular Disorders
- Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease
- (2008) Pietro Minuz et al. HYPERTENSION
- PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
- (2008) Toru Kawai et al. LABORATORY INVESTIGATION
- Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke
- (2008) Kristin D. Marciante et al. Pharmacogenetics and Genomics
- International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions
- (2008) L. A. Stoddart et al. PHARMACOLOGICAL REVIEWS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started